Trademark: 88191876
Status Date
Tuesday, February 23, 2021
Filing Date
Thursday, December 20, 2018
Abandoned Date
Tuesday, February 16, 2021
3 CBD isolate sold in crystal form as an integral ingredient in anti-inflammatory, anti-seizure, anti-nausea, and anti-psychotic ointments, containing CBD with a delta-9 tetrahydrocannabinol (THC) concentration of not more than 0.3 percent on a dry weight basis
Feb 23, 2021
Abandonment Notice Mailed - Incomplete Response
Feb 23, 2021
Abandonment - Incomplete Response
Aug 12, 2020
Notification For Req For Recon Denied No Appeal Filed
Aug 12, 2020
Action For Req For Recon Denied No Appeal Filed E-Mailed
Aug 12, 2020
Action Req For Recon Denied No Appeal Filed Counted Not Mailed
Jul 27, 2020
Teas/Email Correspondence Entered
Jul 27, 2020
Correspondence Received In Law Office
Jul 24, 2020
Assigned To Lie
Jul 10, 2020
Teas Request For Reconsideration Received
Mar 2, 2020
Notification Of Final Refusal Emailed
Mar 2, 2020
Final Refusal E-Mailed
Mar 2, 2020
Final Refusal Written
Feb 8, 2020
Teas/Email Correspondence Entered
Feb 6, 2020
Correspondence Received In Law Office
Feb 6, 2020
Teas Response To Office Action Received
Aug 7, 2019
Notification Of Non-Final Action E-Mailed
Aug 7, 2019
Non-Final Action E-Mailed
Aug 7, 2019
Non-Final Action Written
Jul 29, 2019
Assigned To Examiner
Dec 11, 2018
Assigned To Examiner
Nov 30, 2018
New Application Office Supplied Data Entered In Tram
Nov 16, 2018
New Application Entered In Tram
Trademark Alertz updated from USPTO on 2030-01-24
